Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium.

Slides:

Advertisements

Similar presentations

The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure

Advertisements

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review Journal club presentation

Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.

Johan Rosman Renal Physician and CMO Specialist in Hypertension Waitemata DHB, and Apollo Centre, Albany Omapere, October 09.

6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.

1 The Study of Trandolapril- verapamil And insulin Resistance STAR determined whether glycaemic control was maintained to a greater degree by an RAS inhibitor/non-DHP.

Antihypertensive drugs. BACKGROUND NBP /90-60mmHg, Affecting factors: Volume of blood, Cardiac Output, resistance of Arterioles HBP SBP>140/ DBP>90.

Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal

Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.

Nearly 5 Million Americans Have CHF 400,000 new onset cases diagnosed annually 1400,000 new onset cases diagnosed annually 1 Over 250,000 deaths annually.

Should developing countries continue to use older drugs for essential hypertension? A prescription survey in South Africa suggested that prescribers were.

Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.

Clinical Trial Results. org Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity.

COMET: Carvedilol Or Metoprolol European Trial Purpose To compare the effects of carvedilol (a β 1 -, β 2 - and α 1 -receptor blocker) and short-acting.

High-dose ARB monotherapy versus ARB/CCB combination on cardiovascular events in Japanese elderly high-risk hypertensive patients. The OSCAR trial Ogawa.

Adherence and persistence with medication regimens is highly relevant to disease outcomes.

JNC 7 血壓分期. 血壓分期 JNC 7 ： 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003.

Wald DS, et al. Am J Med 2009;122: Details of the 42 Trials Included in the Meta-analysis - Part I Wald DS, et al. Am J Med 2009;122:

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Renoprotective Effect of Renin-Angiotensin-Aldosterone.

Risk Involved with Dual RAAS Blockade in Kidney Disease Source: Bakris GL. Dual RAAS blockade is desirable in kidney disease: Con. Kidney Int. 2010;78:546–549.

Alarm Sensors: Evaluating the Effectiveness in Reducing Elderly Inpatient Falls Jenna Barnwell, RN Jessica Cantrell, RN Sabrina George, RN Whitney Holman,

Internal Medicine Workshop Series Laos September /October 2009.

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Evidence-based treatment algorithm, including clinical trials published through A, B, and C are levels of evidence defined as follows—Level of Evidence:

Aliskiren and Valsartan for Antihypertensive Therapy Trial

Diagram representing the renin–angiotensin–aldosterone system

Trends in Medication Choices for Hypertension in the Elderly

Isolated Systolic Hypertension: An Update After SPRINT

Valsartan in Acute Myocardial Infarction Trial Investigators

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

David J.A. Jenkins et al. JACC 2018;71:

WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,

Mean BP from initial visit to four years

Creatinine clearance (mL/min) n All-cause mortality (%)

Nat. Rev. Nephrol. doi: /nrneph

Prevalence of statin and beta-blocker use by clinical presentation

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Category Hypertension Normal < 130/< 85 Recheck in 2 years. High Normal 130–139/ 85–89 Recheck in 1 year Hypertension Stage 1 (mild) 140–159/90–99.

Table of Contents Why Do We Treat Hypertension? Recommendation 5

Meta-analysis of randomised phase III clinical trials with ALK inhibitors in non-small cell lung cancer (NSCLC) showing similar benefit in male patients.

Volume 94, Issue 3, Pages (September 2018)

Outcomes with dual RAAS inhibition with an ACE inhibitor and ARB vs standard therapy in patients on hemodialysis with CHF standard therapy in patients.

Hypertension After Kidney Transplant

Volume 72, Issue 12, Pages (December 2007)

Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? Areef Ishani, Charles A. Herzog,

by Ali Albasri, Suman Prinjha, Richard J McManus, and James P Sheppard

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

by Ali Albasri, Suman Prinjha, Richard J McManus, and James P Sheppard

Managing Blood Pressure

Isolated Systolic Hypertension: An Update After SPRINT

Forest plots for randomised and cluster randomised controlled trials from Cochrane review Biomarkers as point-of-care tests to guide prescription of antibiotics.

Kaplan-Meier Curves for the Percentages of Subjects with Microalbuminuria during Treatment with Trandolapril plus Verapamil or Placebo Piero Ruggenenti.

Volume 73, Issue 5, Pages (March 2008)

Difference in the risk of MACEs in patients treated with anti–IL17 agents compared with the placebo in RCTs. IL,interleukin; MACEs, major adverse cardiovascular.

Pulmonary arterial hypertension specific medication use at enrolment among previously diagnosed patients. 184 (7%) of patients were not on a prostaglandin,

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Difference in the risk of MACEs in patients treated with anti-IL23 agents compared with the placebo in RCTs. IL, interleukin; MACEs, major adverse cardiovascular.

PRISMA flow diagram for selection of RCTs from leading sports medicine journals for the publication years 2005 and 2015. PRISMA, Preferred Reporting Items.

(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. (A) Distribution of CsA nephrotoxicity lesions.

Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Difference in the risk of MACEs in patients treated with anti-TNF agents compared with the placebo in RCTs. MACEs, major adverse cardiovascular events;

An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.

Schematic of the interaction between the renin-angiotensin-aldosterone system (RAAS) system and the natriuretic peptides and how the RAAS modulators and.

Flow diagram of studies through the review process

Fig. 3: Possible algorithm for controlling blood pressure in diabetic patients with microalbuminuria. [This algorithm is based on the opinions and practice.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Copyright Notice You are authorized to use these slides subject to the following terms, conditions and exceptions: They are to be used solely for personal,

Presentation transcript:

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema Makani H et al. Am J Med. 2011;124: , METHOD: A MEDLINE/COCHRANE search for randomised controlled trials (RCT) in patients with hypertension, comparing calcium channel blocker (CCB) monotherapy with CCB/renin angiotensin system blocker combination conducted from RCTs reporting the incidence of peripheral edema or withdrawal of patients because of edema and total sample size more than 100 were included in this analysis. 25 RCTs with 17,206 patients (mean age 56 years, 55% were men) and a mean duration of 9.2 weeks..

Combining RAAS inhibitors with CCB decreases edema incidence/withdrawal rates with CCB CCB = calcium channel blocker; RAS = renin-angiotensin system *p< Makani H et al. Am J Med. 2011;124: Percentage

ACE inhibitors are more efficacious than ARBs in reducing CCB-associated edema Makani H et al. Am J Med. 2011;124: P< P=0.0001

Clinical significance The combination of RAAS inhibitors with calcium channel blockers (CCB) reduces the incidence by 38% and withdrawal rate due to peripheral edema by 62% when compared with calcium channel blocker monotherapy. ACE inhibitors were significantly more efficacious than ARBs in reducing the incidence of CCB-associated peripheral edema by 54% and 24%, respectively (P<0.0001), Aliskiren did not show significant reduction of CCB-associated cough. Makani H et al. Am J Med. 2011;124: